Tag: capabilities

SHENZHEN, China, June 16, 2026 /PRNewswire/ -- Shell Recharge and SINEXCEL (300693.SZ) officially signed a Memorandum of Understanding (MoU) and inaugurated the Shell Recharge–SINEXCEL Joint...

SHENZHEN, China, June 16, 2026 /PRNewswire/ -- Shell Recharge and SINEXCEL (300693.SZ) officially signed a Memorandum of Understanding (MoU) and inaugurated the Shell Recharge–SINEXCEL Joint...

HONG KONG, June 16, 2026 /PRNewswire/ -- Tencent Cloud, the cloud business of global leading technology company Tencent, today announced a strategic partnership with...

Starting 16th June, L50s Pro Ultra and L50 Ultra CE will be available on Amazon India, Dreame Technology India website, Croma, and select retail...

HONG KONG, June 16, 2026 /PRNewswire/ -- XTransfer, the world's leading B2B cross-border trade payment platform, is proud to announce that it has been...

REYKJAVIK, Iceland , June 16, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the pricing of its previously announced underwritten public offering (the “Offering”) of 22,666,667 of its ordinary shares at an offering price of $3.75 per share. All ordinary shares to be sold in the Offering will be offered by Alvotech. The Offering is expected to close on or about June 17, 2026, subject to satisfaction of customary closing conditions. The Company has also granted the underwriters a 30-day option to purchase up to an additional 3,400,000 ordinary shares at the public offering price, less underwriting discounts and commissions. Before deducting the underwriting discounts and commissions and offering expenses, the Company expects to receive total gross proceeds of approximately $85 million from the Offering, or approximately $98 million if the underwriters exercise in full their option to purchase additional shares.

KUALA LUMPUR, Malaysia, June 16, 2026 /PRNewswire/ -- Amaron, the flagship battery brand from Amara Raja Energy & Mobility Limited, is set to strengthen its...

TAIPEI, June 15, 2026 /PRNewswire/ -- ACON OPTICS (TWSE: 6820), a leading provider of advanced optical connectivity solutions, showcased its latest innovations in AI...

Functional ingredient innovator outpaces supplement industry growth through proprietary ingredient development, fermentation technology, and expanding global partnershipsBOISE, Idaho, June 15, 2026 /PRNewswire/ -- NNB Nutrition,...

STAMFORD, Conn., June 15, 2026 (GLOBE NEWSWIRE) -- The Lovesac Co. (NASDAQ: LOVE), the Designed for Life home and technology brand best known for its Sactionals, The World's Most Adaptable Couch, today announced it has appointed Andrew Farag as the Company’s Executive Vice President, Chief Financial Officer and Treasurer, effective immediately. He succeeds Keith Siegner who has stepped down from the role but will remain with the Company for a short period to support the transition.

MRD has scaled into a profitable, category-leading MRD diagnostics business, while Immune Medicine has built a differentiated discovery platform powered by proprietary immune data and AI

MRD has scaled into a profitable, category-leading MRD diagnostics business, while Immune Medicine has built a differentiated discovery platform powered by proprietary immune data and AI

According to a new report by Grand View Research, Global Managed Services Market Expected to Grow at a CAGR of 9.9% Through 2033 as...

SHERIDAN, Wyo., June 15, 2026 /PRNewswire/ -- The global laboratory filtration market is projected to grow from USD 4.5 billion in 2025 to USD...